A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
通过四位分析师的专家观点，深入了解health catalyst。
In the last three months, 4 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish.
过去三个月，有4位分析师对Health Catalyst (NASDAQ:HCAT) 发布了评级，从看好到看淡不一。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.12%.
分析师们为Health Catalyst设定了12个月的价格目标，平均目标为11.5美元，最高估值为14.00美元，最低估值为8.00美元。随着分析师将平均目标价下调6.12%，情绪的负向转移显而易见。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
In examining recent analyst actions, we gain...
通过分析最近分...
登录免费看全文
登录/注册